Japan's PMDA releases updated risk report for telaprevir

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1408卷 / 1期

关键词：

Hepatitis; Renal Failure; Chronic Hepatitis; Renal Impairment; Acute Renal Failure;

D O I：

10.2165/00128415-201214080-00002

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[11] Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
Kijima, Shinichi
Ochiai, Yoshinori
Ishiguro, Akihiro
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (10): : 550 - 552
[12] Japan's PMDA presents investigation results
Reactions Weekly, 2015, 1581 (1) : 7 - 7
[13] Investigation results from Japan's PMDA
Reactions Weekly, 2016, 1630 (1) : 1 - 1
[14] Japan PMDA's investigation results for five products
Reactions Weekly, 2018, 1686 (1) : 5 - 5
[15] Japan PMDA's investigation results for May 2019
Reactions Weekly, 2019, 1753 (1) : 3 - 3
[16] Japan's PMDA investigation results for four products
Reactions Weekly, 2017, 1655 (1) : 2 - 2
[17] Japan's PMDA investigation results for March 2019
Reactions Weekly, 2019, 1747 (1) : 2 - 2
[18] Japan's PMDA investigation results for February 2018
Reactions Weekly, 2018, 1690 (1) : 2 - 2
[19] Recent investigation results from Japan's PMDA
Reactions Weekly, 2019, 1773 (1) : 3 - 3
[20] Japan's PMDA reviews renal contraindications for metformin
Reactions Weekly, 2019, 1767 (1) : 1 - 1

← 1 2 3 4 5 →